Medically reviewed by Doru Paul, MD To confirm a psoriasis diagnosis, your healthcare provider will check your skin and scalp ...

Deucravacitinib outperformed placebo for treating moderate to severe scalp psoriasis, even among patients with less extensive ...

Topline results were announced from a phase 3 trial evaluating icotrokinra in patients with moderate to severe plaque psoriasis (PsO).

Risankizumab had greater improvements in skin clearance and quality of life at 16 weeks in patients with psoriasis compared with deucravacitinib.

THUMBS UP & SUBSCRIBE HERE- <a href=" Thena Natural Wellness's Best Skin Healing Cream For Eczema, Psoriasis, Rosacea, Dermatitis, Heat Rash, Hives & More No more severely dry, itchy, scaly, cracked, ...

Icotrokinra is an investigational oral peptide that blocks interleukin (IL)-23 receptor, which plays a significant role in ...

Scientists from The Second Affiliated Hospital of Zhejiang University have found a potential link between psoriasis, a ...

The study was conducted among patients with plaque psoriasis affecting special areas such as the scalp, genitals and/or hands ...

Psoriasis is a typical chronic inflammatory disease. Typical symptoms are thick plates of silvery white keratin that usually ...